| Literature DB >> 21660133 |
A S de Mello1, F B Mendes, K Michelin-Tireli, M V Camelier, J C Coelho.
Abstract
BACKGROUND: The Epstein-Barr virus (EBV) was used as an agent of B lymphocyte proliferation for subsequent diagnosis of lysosomal storage disease. Due to the constant handling of long-preserved samples in our cell bank, we decided to observe the behavior and then compare cultured and frozen samples for at least one year's cryopreservation.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21660133 PMCID: PMC3110302 DOI: 10.1155/2011/132581
Source DB: PubMed Journal: J Biomed Biotechnol ISSN: 1110-7243
Figure 1Evaluation of LCL's transformation by electron microscopy: (a) (0.5 μm), (b) (0.5 μm), (e) (1 μm)—Lymphocytes before transformation. (c) (300 nm), (d) (300 nm), (f) (1 μm)—Lymphocytes after transformation. Bn: binucleation, c: cytoplasm, m: mitochondria, n: nucleus, re: endoplasmic reticulum.
Figure 2Enzymatic analysis of acid hydrolases from LCLs. Data are expressed as mean + standard deviation. β-gluco: β-glucosidase, α-gal: α-galactosidase, β-gal: β-galactosidase, α-gluco: α-glucosidase, and α-iduro: α-iduronidase.